​

Immatics (IMTX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

IMTX Stock Forecast

Immatics (IMTX) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $17.33, with a high of $19.00 and a low of $16.00. This represents a 72.44% increase from the last price of $10.05.

$5 $8 $11 $14 $17 $20 High: $19 Avg: $17.33 Low: $16 Last Closed Price: $10.05

IMTX Stock Rating

Immatics stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

IMTX Price Target Upside V Benchmarks

TypeNameUpside
StockImmatics72.44%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts133
Avg Price Target$17.00$17.33$17.33
Last Closing Price$10.05$10.05$10.05
Upside/Downside69.15%72.44%72.44%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25-9---9
Nov, 25-9---9
Oct, 25-9---9
Sep, 25-8---8
Aug, 2517---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 04, 2025Jonathan ChangLeerink Partners$17.00$10.1467.65%69.15%
Oct 29, 2025Graig SuvannavejhMizuho Securities$19.00$10.3683.40%89.05%
Sep 17, 2025Paul JengGuggenheim$16.00$6.03165.34%59.20%
May 16, 2024Graig SuvannavejhMizuho Securities$16.00$11.0844.40%59.20%
Aug 09, 2022Geulah LivshitsChardan Capital$28.00$12.43125.26%178.61%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 04, 2025Leerink PartnersOutperformOutperformhold
Sep 17, 2025GuggenheimBuyinitialise
May 28, 2025Deutsche BankBuyinitialise
Nov 18, 2024Bank of America SecuritiesBuyBuyhold
Oct 07, 2024Piper SandlerOverweightinitialise

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-4.78$-1.51$0.56$-1.20-----
Avg Forecast$-4.14$-1.51$0.64$-1.20$-0.63$-1.14$-1.51$-1.75$-1.88
High Forecast$-3.44$-1.25$0.79$-1.13$-0.41$-0.90$-1.36$-1.48$-1.28
Low Forecast$-4.87$-1.77$0.52$-1.30$-0.89$-1.48$-1.66$-2.03$-2.65
Surprise %15.46%--12.50%------

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$31.25M$34.76M$172.83M$54.00M-----
Avg Forecast$29.30M$31.72M$152.54M$50.81M$114.54M$64.88M$54.44M$54.03M$130.06M
High Forecast$33.27M$36.01M$179.56M$56.28M$118.60M$75.51M$71.43M$70.90M$170.66M
Low Forecast$25.50M$27.61M$130.61M$44.65M$111.28M$54.16M$41.06M$40.75M$98.08M
Surprise %6.67%9.60%13.30%6.27%-----

Net Income Forecast

$-400M $-310M $-220M $-130M $-40M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-229.35M$-95.06M$37.51M$-96.99M-----
Avg Forecast$-333.65M$2.93M$2.65M$-88.14M$-49.95M$-96.04M$-121.45M$-141.40M$-151.62M
High Forecast$-277.43M$3.30M$2.85M$-77.89M$-32.90M$-72.88M$-109.49M$-119.40M$-103.15M
Low Forecast$-392.38M$2.32M$2.63M$-111.45M$-71.61M$-119.19M$-133.41M$-163.40M$-213.14M
Surprise %-31.26%-3346.70%1313.32%10.05%-----

IMTX Forecast FAQ

Is Immatics stock a buy?

Immatics stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Immatics is a favorable investment for most analysts.

What is Immatics's price target?

Immatics's price target, set by 8 Wall Street analysts, averages $17.33 over the next 12 months. The price target range spans from $16 at the low end to $19 at the high end, suggesting a potential 72.44% change from the previous closing price of $10.05.

How does Immatics stock forecast compare to its benchmarks?

Immatics's stock forecast shows a 72.44% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Immatics over the past three months?

  • December 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Immatics’s EPS forecast?

Immatics's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.63, marking a -47.50% decrease from the reported $-1.2 in 2023. Estimates for the following years are $-1.14 in 2025, $-1.51 in 2026, $-1.75 in 2027, and $-1.88 in 2028.

What is Immatics’s revenue forecast?

Immatics's average annual revenue forecast for its fiscal year ending in December 2024 is $114.54M, reflecting a 112.12% increase from the reported $54M in 2023. The forecast for 2025 is $64.88M, followed by $54.44M for 2026, $54.03M for 2027, and $130.06M for 2028.

What is Immatics’s net income forecast?

Immatics's net income forecast for the fiscal year ending in December 2024 stands at $-49.95M, representing a -48.50% decrease from the reported $-96.994M in 2023. Projections indicate $-96.038M in 2025, $-121M in 2026, $-141M in 2027, and $-152M in 2028.